Male C57/BL6 mice weighing 21–24 g were divided into three groups (n=6 in each group): (i) sham-operated mice, (ii) UIRI mice injected with control shRNA, and (iii) UIRI mice injected with FBN1-shRNA. Four days after IRI, mice were injected with either pLVX-shFBN1 or control (pLVX-control) plasmids via tail vein injection using hydrodynamics-based gene transfer approach. Plasmids were diluted with sterile PBS. The amount of plasmid for mice was 1 mg per kg body weight. The fluid volume via tail-vein injection of each mouse is about 10% of the body weight, and FBN1 or control shRNA should be rapidly administered (within 10 seconds) into mice via tail-vein injection. Mice were euthanized at 11 days after IRI, and serum and kidney tissues were analyzed.
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Fu, H and Liu, Y(2022). Knockdown of FBN1 in vivo. Bio-protocol Preprint. bio-protocol.org/prep1575.
Li, L., Liao, J., Yuan, Q., Hong, X., Li, J., Peng, Y., He, M., Zhu, H., Zhu, M., Hou, F. F., Fu, H. and Liu, Y.(2021). Fibrillin-1–enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease. Science Advances 7(5). DOI: 10.1126/sciadv.abc7170
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.